Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma

被引:5
作者
Ju, Feng [1 ]
Wang, Dawei [2 ]
Huang, Lan [3 ]
Jiang, Chun [3 ]
Gao, Ce [3 ]
Xiong, Cunquan [4 ]
Zhai, Guanghua [3 ]
机构
[1] Yangzhou Univ, Jianhu Clin Coll, Dept Lab Med, Yangzhou, Jianhu, Peoples R China
[2] Second Peoples Hosp Yancheng City, Dept Infect Dis, Yancheng, Peoples R China
[3] Nanjing Med Univ, Affiliated Suzhou Hosp, Dept Clin Lab, Suzhou Municipal Hosp,Gusu Sch, Suzhou, Jiangsu, Peoples R China
[4] Jiangsu Vocat Coll Med, Coll Pharm, Yancheng, Jiangsu, Peoples R China
关键词
liver transplantation; HCC; PD-1; PD-L1 signaling pathway; ICI; immune tolerance; T-CELLS; CHECKPOINT INHIBITORS; PD-1; EXPRESSION; REJECTION; CANCER; RECURRENCE; TOLERANCE; DIAGNOSIS; THERAPY;
D O I
10.3389/fimmu.2023.1227756
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Primary liver cancer is one of the most common malignant tumors in China. The vast majority of primary liver cancer are hepatocellular carcinoma. Due to its high incidence and mortality from HCC, HCC has always been a feared type of cancer. Liver transplantation, as one of the important means to treat advanced liver cancer, has brought new hope to patients. However, as patients have been in a state of immunosuppression after liver transplantation, these patients face new problems of HCC recurrence and metastasis. A increasing number of studies have proved that blocking the PD-1/PD-L1 signaling pathway and restoring the immune killing inhibition of T cells can produce better therapeutic effects on tumors and chronic infectious diseases. As a promising treatment in the field of tumor immunotherapy, PD-1/PD-L1 inhibitors have achieved important results in liver cancer patients, but their application in liver transplantation patients is still highly controversial. This paper will introduce the mechanism of action of PD-1/PD-L1 signaling pathway and the current basic and clinical studies of PD-1/PD-L1 signaling pathway associated with immune response in HCC transplantation.
引用
收藏
页数:7
相关论文
共 70 条
[1]   PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome [J].
Alsaab, Hashem O. ;
Sau, Samaresh ;
Alzhrani, Rami ;
Tatiparti, Katyayani ;
Bhise, Ketki ;
Kashaw, Sushil K. ;
Iyer, Arun K. .
FRONTIERS IN PHARMACOLOGY, 2017, 8
[2]   PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes [J].
Ben Nasr, Moufida ;
Tezza, Sara ;
D'Addio, Francesca ;
Mameli, Chiara ;
Usuelli, Vera ;
Maestroni, Anna ;
Corradi, Domenico ;
Belletti, Silvana ;
Albarello, Luca ;
Becchi, Gabriella ;
Fadini, Gian Paolo ;
Schuetz, Christian ;
Markmann, James ;
Wasserfall, Clive ;
Zon, Leonard ;
Zuccotti, Gian Vincenzo ;
Fiorina, Paolo .
SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (416)
[3]   Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation [J].
Carter, LL ;
Carreno, BM .
IMMUNOLOGIC RESEARCH, 2003, 28 (01) :49-59
[4]   Role of PD-1 in Immunity and Diseases [J].
Chamoto, Kenji ;
Al-Habsi, Muna ;
Honjo, Tasuku .
EMERGING CONCEPTS TARGETING IMMUNE CHECKPOINTS IN CANCER AND AUTOIMMUNITY, 2017, 410 :75-97
[5]   T-helper type 2 cell-directed therapy for asthma [J].
Cohn, L ;
Ray, A .
PHARMACOLOGY & THERAPEUTICS, 2000, 88 (02) :187-196
[6]   The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA [J].
Croft, M .
TRENDS IN IMMUNOLOGY, 2005, 26 (06) :292-294
[7]   Impact of nitric oxide in liver cancer microenvironment [J].
Dios-Barbeito, Sandra ;
Gonzalez, Raul ;
Cadenas, Miryam ;
Garcia, Lisander F. ;
Victor, Victor M. ;
Padillo, Francisco J. ;
Muntan, Jordi .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2022, 128 :1-11
[8]   CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naive Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment [J].
Edwards, Jarem ;
Wilmott, James S. ;
Madore, Jason ;
Gide, Tuba Nur ;
Quek, Camelia ;
Tasker, Annie ;
Ferguson, Angela ;
Chen, Jinbiao ;
Hewavisenti, Rehana ;
Hersey, Peter ;
Gebhardt, Thomas ;
Weninger, Wolfgang ;
Britton, Warwick J. ;
Saw, Robyn P. M. ;
Thompson, John F. ;
Menzies, Alexander M. ;
Long, Georgina V. ;
Scolyer, Richard A. ;
Palendira, Umaimainthan .
CLINICAL CANCER RESEARCH, 2018, 24 (13) :3036-3045
[9]   Immune Checkpoint Inhibitors in Solid Organ Transplant Recipients With Advanced Skin Cancers-Emerging Strategies for Clinical Management [J].
Ferrandiz-Pulido, Carla ;
Leiter, Ulrike ;
Harwood, Catherine ;
Proby, Charlotte M. ;
Guthoff, Martina ;
Scheel, Christina H. ;
Westhoff, Timm H. ;
Bouwes Bavinck, Jan Nico ;
Meyer, Thomas ;
Naegeli, Mirjam C. ;
del Marmol, Veronique ;
Lebbe, Celeste ;
Geusau, Alexandra .
TRANSPLANTATION, 2023, 107 (07) :1452-1462
[10]   Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways [J].
Fife, Brian T. ;
Bluestone, Jeffrey A. .
IMMUNOLOGICAL REVIEWS, 2008, 224 :166-182